NanOlogy
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3909 Hulen St Fl 4, Fort Worth, Texas, 7...Phone Number
(425) 306-8716Website
www.nanology.usRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NanOlogy
NanOlogy is focused on enhancing the treatment of solid tumors through a local precision approach that minimizes toxicity, utilizing their proprietary Purcision particle engineering technology. Their patented large surface area microparticles (LSAMs) are designed for intratumoral delivery, allowing for sustained drug release at the tumor site while maintaining low systemic levels. The company aims to support both local and metastatic disease treatment in combination with standard therapies, backed by clinical results demonstrating their investigational drugs' therapeutic potential. NanOlogy targets physicians and patients interested in innovative cancer treatment solutions.Explore more
NanOlogy Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NanOlogy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if NanOlogy has recently received funding, and reach out quickly before it becomes old news!
NanOlogy, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if NanOlogy had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NanOlogy
Funding: Get notified immidiatlly once NanOlogy has new funding data
Product Launch: Get notified when NanOlogy launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NanOlogy recently announced quarterly report
Check out if NanOlogy is spiking on competitors!
Recommended Actions
Find VP level buyers at NanOlogy
Find 3 more new buyers
Compare Similar Companies to NanOlogy
Compare insights from companies similar to NanOlogy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NanOlogy is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NanOlogy is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NanOlogy.
NanOlogy Tech Stack
A closer look at the technologies used by NanOlogy
See more technologies
Most Recent Scoops
Event
Person-Based
Events, Podcast
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Event
Events
NanOlogy News & Media
NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio
FORT WORTH, Texas, Jan. 6, 2026 /PRNewswire/ -- NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of John M. Goldberg, MD as fractional Chief Medical Officer (CMO) to advance development of its Large Surface Area Microparticle (LSAM) drug portfolio...NanOlogy Names CEO as Its Tumor-Targeted Cancer Drugs Near Key Regulatory Milestones
NanOlogy CEO appointment names David Arthur to lead the Fort Worth clinical-stage oncology company and advance its LSAM drug development programs.NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio
FORT WORTH, Texas, Dec. 17, 2025 /PRNewswire/ -- NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of David Arthur as Chief Executive Officer. This appointment reflects a pivotal step in NanOlogy's commitment to accelerating development of its LSAM drug...NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor
Next Generation Intratumoral Technology Targets Diffuse Intrinsic Pontine Glioma Investigational New Drug Enabling Studies are Underway with Planned Clinical Trial to Begin Late 2026 FORT WORTH, Texas, Dec. 11, 2025 /PRNewswire/ -- NanOlogy, LLC, a private clinical-stage oncology company,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NanOlogy
Sign Up For FreeTo access detailed company insights
NanOlogy is focused on enhancing the treatment of solid tumors through a local precision approach that minimizes toxicity, utilizing their proprietary Purcision particle engineering technology. Their patented large surface area microparticles (LSAMs) are designed for intratumoral delivery, allowing for sustained drug release at the tumor site while... Read More
